-
The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.
Pharmacol Ther. 1998 May;78(2):55-113
PMID: 9623881
-
Tissue-specific codon usage and the expression of human genes.
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12588-91
PMID: 15314228
-
Monitoring activation of ribonuclease L by 2',5'-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells.
Methods Enzymol. 2001;342:10-20
PMID: 11586885
-
Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR.
J Virol. 2002 Feb;76(3):1265-72
PMID: 11773402
-
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.
Hepatology. 2003 Sep;38(3):645-52
PMID: 12939591
-
Genetic diversity and evolution of hepatitis C virus--15 years on.
J Gen Virol. 2004 Nov;85(Pt 11):3173-88
PMID: 15483230
-
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
N Engl J Med. 1998 Nov 19;339(21):1485-92
PMID: 9819446
-
Retention and repression: fates of hyperedited RNAs in the nucleus.
Curr Opin Cell Biol. 2005 Jun;17(3):302-8
PMID: 15901501
-
Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.
Virology. 1999 Sep 15;262(1):250-63
PMID: 10489358
-
Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2986-91
PMID: 15710892
-
Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin.
Liver Int. 2003 Dec;23(6):426-33
PMID: 14986817
-
A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication.
J Virol. 2004 Feb;78(3):1352-66
PMID: 14722290
-
Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response.
J Infect Dis. 2000 Feb;181(2):432-41
PMID: 10669323
-
Assays for poliovirus polymerase, 3D(Pol), and authentic RNA replication in HeLa S10 extracts.
Methods Enzymol. 1996;275:35-57
PMID: 9026649
-
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.
Science. 2006 Nov 10;314(5801):997-1001
PMID: 17038589
-
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.
Science. 1997 Jul 25;277(5325):570-4
PMID: 9228008
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.
Lancet. 2001 Sep 22;358(9286):958-65
PMID: 11583749
-
Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.
Mol Cell Biol. 1998 Sep;18(9):5208-18
PMID: 9710605
-
Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.
RNA. 2002 Apr;8(4):512-25
PMID: 11991644
-
A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.
Antiviral Res. 2006 Mar;69(3):129-41
PMID: 16413618
-
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.
J Viral Hepat. 2001 Nov;8(6):414-20
PMID: 11703572
-
Evolution of the genome and the genetic code: selection at the dinucleotide level by methylation and polyribonucleotide cleavage.
Proc Natl Acad Sci U S A. 1989 Jan;86(1):192-6
PMID: 2463621
-
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15661-8
PMID: 12441397
-
A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.
J Virol. 2007 Jun;81(11):5561-72
PMID: 17344297
-
5'-Triphosphate RNA is the ligand for RIG-I.
Science. 2006 Nov 10;314(5801):994-7
PMID: 17038590
-
Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p.
RNA. 2001 Mar;7(3):361-73
PMID: 11333017
-
GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.
Antiviral Res. 2001 Dec;52(3):241-9
PMID: 11675141
-
Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
EMBO J. 2004 Oct 13;23(20):3929-38
PMID: 15385955
-
Detection of genome-scale ordered RNA structure (GORS) in genomes of positive-stranded RNA viruses: Implications for virus evolution and host persistence.
RNA. 2004 Sep;10(9):1337-51
PMID: 15273323
-
Structural constraints on RNA virus evolution.
J Virol. 1999 Jul;73(7):5787-94
PMID: 10364330
-
CARD games between virus and host get a new player.
Trends Immunol. 2006 Jan;27(1):1-4
PMID: 16309964
-
Mapping of the human RNASEL promoter and expression in cancer and normal cells.
J Interferon Cytokine Res. 2005 Oct;25(10):595-603
PMID: 16241858
-
EMBOSS: the European Molecular Biology Open Software Suite.
Trends Genet. 2000 Jun;16(6):276-7
PMID: 10827456
-
Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.
Hepatology. 1997 Nov;26(5):1322-7
PMID: 9362379
-
Amino acid substitutions in PKR-eIF2 phosphorylation homology domain (PePHD) of hepatitis C virus E2 protein in genotype 2a/2b and 1b in Japan and interferon efficacy.
Hepatol Res. 2003 Aug;26(4):268-274
PMID: 12963425
-
The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells.
J Viral Hepat. 2006 Mar;13(3):150-7
PMID: 16475990
-
The extent of codon usage bias in human RNA viruses and its evolutionary origin.
Virus Res. 2003 Mar;92(1):1-7
PMID: 12606071
-
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.
Science. 1999 Jul 2;285(5424):107-10
PMID: 10390359
-
Evasion of intracellular host defence by hepatitis C virus.
Nature. 2005 Aug 18;436(7053):939-45
PMID: 16107833
-
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):6001-6
PMID: 16585524
-
Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain.
J Virol. 2001 Feb;75(3):1265-73
PMID: 11152499
-
Poliovirus CRE-dependent VPg uridylylation is required for positive-strand RNA synthesis but not for negative-strand RNA synthesis.
J Virol. 2003 Apr;77(8):4739-50
PMID: 12663781
-
Hearing silence: non-neutral evolution at synonymous sites in mammals.
Nat Rev Genet. 2006 Feb;7(2):98-108
PMID: 16418745
-
RNA editing in hepatitis delta virus genotype III requires a branched double-hairpin RNA structure.
J Virol. 2002 Aug;76(15):7385-97
PMID: 12097551
-
Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons.
J Virol. 2003 Oct;77(20):10769-79
PMID: 14512527
-
Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome.
J Mol Evol. 1997 Sep;45(3):238-46
PMID: 9302317
-
Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.
EMBO J. 1997 Nov 3;16(21):6355-63
PMID: 9351818
-
Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: comparison with interferon alpha alone.
J Gastroenterol Hepatol. 1998 Dec;13(12):1249-53
PMID: 9918434
-
Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites.
J Interferon Cytokine Res. 2004 Nov;24(11):664-76
PMID: 15684820
-
Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2.
J Virol. 2001 Sep;75(18):8547-55
PMID: 11507200
-
Coupled translation and replication of poliovirus RNA in vitro: synthesis of functional 3D polymerase and infectious virus.
J Virol. 1993 Feb;67(2):822-31
PMID: 8380467
-
Cardif: a protein central to innate immunity is inactivated by the HCV NS3 serine protease.
Hepatology. 2006 Mar;43(3):615-7
PMID: 16496328
-
Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.
J Clin Invest. 1995 Jul;96(1):224-30
PMID: 7542279
-
Epidemiology of hepatitis C.
Hepatology. 1997 Sep;26(3 Suppl 1):62S-65S
PMID: 9305666
-
Dinucleotide and stop codon frequencies in single-stranded RNA viruses.
J Gen Virol. 1997 Nov;78 ( Pt 11):2859-70
PMID: 9367373
-
Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.
J Med Virol. 1999 Apr;57(4):370-5
PMID: 10089049
-
The Los Alamos hepatitis C sequence database.
Bioinformatics. 2005 Feb 1;21(3):379-84
PMID: 15377502
-
Effect of alpha interferon on the hepatitis C virus replicon.
J Virol. 2001 Sep;75(18):8516-23
PMID: 11507197
-
The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
N Engl J Med. 1997 Mar 13;336(11):747-54
PMID: 9052652
-
Selective RNA cleavage by isolated RNase L activated with 2-5A antisense chimeric oligonucleotides.
Methods Enzymol. 2000;313:522-33
PMID: 10595377
-
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.
Nature. 2005 Oct 20;437(7062):1167-72
PMID: 16177806
-
Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy.
J Viral Hepat. 2005 Sep;12(5):465-72
PMID: 16108760
-
Complete replication of poliovirus in vitro: preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA.
J Virol. 1995 Sep;69(9):5516-27
PMID: 7636997
-
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.
Ann Intern Med. 2006 May 16;144(10):705-14
PMID: 16702586
-
Retroviral restriction by APOBEC proteins.
Nat Rev Immunol. 2004 Nov;4(11):868-77
PMID: 15516966